Loading data
TCRTNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 5 k USD | 10 k USD | 5 k USD | 2.92 m USD | 398 k USD |
| Research and development expense | 1.36 m USD | 362 k USD | 16.28 m USD | 25.02 m USD | 49.64 m USD |
| Operating profit | -4.23 m USD | -4.81 m USD | -34.27 m USD | -35.11 m USD | -77.55 m USD |
| Interest expense | — | — | 1.92 m USD | 3.15 m USD | 1.19 m USD |
| Income tax expense | 0 USD | — | — | — | — |
| Net income (reported basis) | -4.18 m USD | -4.68 m USD | -4.68 m USD | -37.73 m USD | -78.75 m USD |
| Net income attributable to common shareholders | -4.28 m USD | -4.68 m USD | — | — | — |
| Basic earnings per share | -2.2 USD/share | -2.92 USD/share | -21.97 USD/share | -2.61 USD/share | -0.37 USD/share |
| Diluted earnings per share | -2.2 USD/share | -2.92 USD/share | -21.97 USD/share | -2.61 USD/share | -0.37 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.